Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 124

Similar articles for PubMed (Select 10918763)

1.

Changes in radical prostatectomy and radiation therapy rates for African Americans and whites.

Shaw M, Elterman L, Rubenstein M, McKiel CF, Guinan P.

J Natl Med Assoc. 2000 Jun;92(6):281-4.

2.

Racial differences in initial treatment for clinically localized prostate cancer. Results from the prostate cancer outcomes study.

Hoffman RM, Harlan LC, Klabunde CN, Gilliland FD, Stephenson RA, Hunt WC, Potosky AL.

J Gen Intern Med. 2003 Oct;18(10):845-53.

3.

Impact of race on prostate-specific antigen outcome after radical prostatectomy for clinically localized adenocarcinoma of the prostate.

Cross CK, Shultz D, Malkowicz SB, Huang WC, Whittington R, Tomaszewski JE, Renshaw AA, Richie JP, D'Amico AV.

J Clin Oncol. 2002 Jun 15;20(12):2863-8.

PMID:
12065563
4.

Racial differences in serum prostate-specific antigen (PSA) doubling time, histopathological variables and long-term PSA recurrence between African-American and white American men undergoing radical prostatectomy for clinically localized prostate cancer.

Tewari A, Horninger W, Badani KK, Hasan M, Coon S, Crawford ED, Gamito EJ, Wei J, Taub D, Montie J, Porter C, Divine GW, Bartsch G, Menon M.

BJU Int. 2005 Jul;96(1):29-33.

PMID:
15963115
5.

Improved biochemical outcome with adjuvant radiotherapy after radical prostatectomy for prostate cancer with poor pathologic features.

Vargas C, Kestin LL, Weed DW, Krauss D, Vicini FA, Martinez AA.

Int J Radiat Oncol Biol Phys. 2005 Mar 1;61(3):714-24.

PMID:
15708249
6.

Racial treatment trends in localized/regional prostate carcinoma: 1992-1999.

Underwood W 3rd, Jackson J, Wei JT, Dunn R, Baker E, Demonner S, Wood DP.

Cancer. 2005 Feb 1;103(3):538-45.

7.

Disease-free survival difference between African Americans and whites after radical prostatectomy for local prostate cancer: a multivariable analysis.

Powell IJ, Dey J, Dudley A, Pontes JE, Cher ML, Sakr W, Grignon DJ, Wood DP.

Urology. 2002 Jun;59(6):907-12.

PMID:
12031379
8.
9.

Prostate cancer in African-American men: outcome following radiation therapy with or without adjuvant androgen ablation.

Zagars GK, Pollack A, Pettaway CA.

Int J Radiat Oncol Biol Phys. 1998 Oct 1;42(3):517-23.

PMID:
9806509
10.

Geographic, age, and racial variation in the treatment of local/regional carcinoma of the prostate.

Harlan L, Brawley O, Pommerenke F, Wali P, Kramer B.

J Clin Oncol. 1995 Jan;13(1):93-100.

PMID:
7799048
11.
13.
14.

Epidemiology of radical prostatectomy for localized prostate cancer in the era of prostate-specific antigen: an overview of the Department of Defense Center for Prostate Disease Research national database.

Moul JW, Wu H, Sun L, McLeod DG, Amling C, Lance R, Kusuda L, Donahue T, Foley J, Chung A, Sexton W, Soderdahl D, Rich NM.

Surgery. 2002 Aug;132(2):213-9.

PMID:
12219014
15.

Stage T1-2 prostate cancer with pretreatment prostate-specific antigen level < or = 10 ng/ml: radiation therapy or surgery?

Keyser D, Kupelian PA, Zippe CD, Levin HS, Klein EA.

Int J Radiat Oncol Biol Phys. 1997 Jul 1;38(4):723-9.

PMID:
9240638
16.

Identification of factors predicting response to adjuvant radiation therapy in patients with positive margins after radical prostatectomy.

Kamat AM, Babaian K, Cheung MR, Naya Y, Huang SH, Kuban D, Babaian RJ.

J Urol. 2003 Nov;170(5):1860-3.

PMID:
14532793
17.

Outcome of salvage radiotherapy for biochemical failure after radical prostatectomy with or without hormonal therapy.

Cheung R, Kamat AM, de Crevoisier R, Allen PK, Lee AK, Tucker SL, Pisters L, Babaian RJ, Kuban D.

Int J Radiat Oncol Biol Phys. 2005 Sep 1;63(1):134-40.

PMID:
16111581
18.

Predictors of prostate cancer-specific mortality after radical prostatectomy or radiation therapy.

Zhou P, Chen MH, McLeod D, Carroll PR, Moul JW, D'Amico AV.

J Clin Oncol. 2005 Oct 1;23(28):6992-8.

19.

Prostate-specific antigen levels in African-Americans correlate with insurance status as an indicator of socioeconomic status.

Vijayakumar S, Weichselbaum R, Vaida F, Dale W, Hellman S.

Cancer J Sci Am. 1996 Jul-Aug;2(4):225-33.

PMID:
9166537
20.

Postprostatectomy cancer-free survival of African Americans is similar to non-African Americans after adjustment for baseline cancer severity.

Underwood W 3rd, Wei J, Rubin MA, Montie JE, Resh J, Sanda MG.

Urol Oncol. 2004 Jan-Feb;22(1):20-4.

PMID:
14969799
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk